Acuta Capital Partners’s Indaptus Therapeutics INDP Stock Holding History

Acuta Capital Partners’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,323	Closed	-$13M	–	43
2018 Q2	$13M	Buy	1,323 +107	+9%	+$1.19M	2.57%	11
2018 Q1	$17.2M	Hold	1,216	–	–	3.61%	11
2017 Q4	$14M	Hold	1,216	–	–	3.48%	13
2017 Q3	$24.4M	Buy	1,216 +1,037	+579%	+$15M	6.57%	7
2017 Q2	$2.28M	Buy	+179	New	+$2.17M	0.93%	30

Other funds holding INDP

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

David M. Knott $264M AUM 59.23% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return